Tavanta Therapeutics to Showcase Specialty Pipeline During the 2023 ASCO
31 May 2023 //
PR NEWSWIRE
Tavanta Announces New Data for its Cystic Fibrosis Candidate TAVT-135
24 May 2023 //
PR NEWSWIRE
Tavanta Announces Positive Top-line Results from Pivotal Phase 3 Trial
05 Jan 2023 //
PR NEWSWIRE
Tavanta Therapeutics to Present Preclinical Data for TAVT-135
28 Oct 2022 //
PRNEWSWIRE